Business
Ocumetics Announces Lens Design Freeze for First-in-Human Study
(TheNewswire) Calgary, Alberta – TheNewswire - May 12 2025 - Ocumetics Tec...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Announces Lens Design Freeze for First-in-Human Study\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta –\n \n\n TheNewswire -\n \n\n May 12 2025\n \n - Ocumetics Technology\nCorp\n \n .\n \n (“Ocumetics” or the\n“Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in\nadvanced ophthalmic technology, is pleased to announce\n \n the successful completion of its optimized lens prototype\ndesign. With this milestone, Ocumetics has formally initiated a design\nfreeze - locking in lens specifications that will be used in its\nupcoming first-in-human (FIH) clinical study planned for summer\n2025.\n \n\n\n\n Dean Burns, CEO of Ocumetics, stated: “This is a\ndefining milestone for Ocumetics.  This optimized lens design\nreflects our commitment to precision, performance, and patient safety.\nWith the design now locked, we can advance with the manufacturing and\nregulatory processes leading up to our first-in-human studies planned\nfor this summer. With each completed step the path to delivering a\ntransformative solution for vision correction is clearer than\never.”\n \n\n\n\n This decision follows a series of rigorous design\noptimizations, bench testing, and laboratory performance validations,\nincluding recent success in achieving the accommodative response\nnecessary to proceed with first-in-human trials. The finalized\nprototype integrates Ocumetics’ most advanced optical design,\nbiomechanical engineering, and proprietary manufacturing methods,\nrepresenting a new era in accommodative intraocular lens\ntechnology.\n \n\n\n\n Dr. Garth Webb, Founder and Chief Scientific Officer\nof Ocumetics, added: “Finalizing the design of the Ocumetics Lens\nis a momentous achievement that reflects the culmination of years of\nresearch, innovation, and teamwork. This design freeze marks a\ntransition from concept to reality, and we are thrilled to be\nadvancing toward the first-in-human studies with a lens we believe has\nthe potential to redefine visual restoration.”\n \n\n\n\n The finalized design will now undergo final\nmanufacturing scale-up and sterility validation procedures to prepare\nfor clinical-grade production. The FIH study is a critical next step\nin Ocumetics’ mis...